Lidocaine: neurobiological targets and effects on the auditory system

Progress in Brain Research

Volumn 166, Issue , 2007, Pages 303-322

  Trellakis, Sokratis ^a   Lautermann, Juergen ^a   Lehnerdt, Goetz ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

anesthetics, local; auditory system; hearing; ion channels; lidocaine; neurons; receptors; tinnitus

Indexed keywords

4 AMINOBUTYRIC ACID; CALCIUM CHANNEL; GLUTAMIC ACID; GLYCINE; ION CHANNEL; LIDOCAINE; POTASSIUM CHANNEL; SODIUM CHANNEL; VANILLOID RECEPTOR;

AUDITORY SYSTEM; BINDING SITE; CHEMICAL STRUCTURE; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; HUMAN; LOCAL ANESTHESIA; NERVE CELL PLASTICITY; NEUROIMAGING; PRIORITY JOURNAL; REVIEW; TINNITUS;

ANESTHETICS, LOCAL; ANIMALS; AUDITORY PATHWAYS; HUMANS; ION CHANNELS; LIDOCAINE; TINNITUS;

EID: 35348822571     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(07)66028-2     Document Type: Review

References (173)

1. Abbott S.D., Hughes L.F., Bauer C.A., Salvi R., and Caspary D.M. Detection of glutamate decarboxylase isoforms in rat inferior colliculus following acoustic exposure. Neuroscience 93 (1999) 1375-1381
2. Abdi S., Lee D.H., and Chung J.M. The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain. Anesth. Analg. 87 (1998) 1360-1366
3. Akerman B., Astrom A., Ross S., and Telc A. Studies on the absorption, distribution and metabolism of labelled prilocaine and lidocaine in some animal species. Acta Pharmacol. Toxicol. (Copenh.) 24 (1966) 389-403
4. d'Aldin C.G., Ruel J., Assie R., Pujol R., and Pujol J.L. Implication of NMDA type glutamate receptors in neural regeneration and neoformation of synapses after excitotoxic injury in the guinea pig cochlea. Int. J. Dev. Neurosci. 15 (1997) 619-629
5. Andersson G., Lyttkens L., Hirvela C., Furmark T., Tillfors M., and Fredrikson M. Regional cerebral blood flow during tinnitus: a PET case study with lidocaine and auditory stimulation. Acta Otolaryngol. 120 (2000) 967-972
6. Attal N., Gaude V., Brasseur L., Dupuy M., Guirimand F., Parker F., and Bouhassira D. Intravenous lidocaine in central pain: a double bind, placebo-controlled, psychophysical study. Neurology 54 (2000) 564-574
7. Baguley D.M., Jones S., Wilkins I., Axon P.R., and Moffat D.A. The inhibitory effect of intravenous lidocaine infusion on tinnitus after translabyrinthine removal of vestibular schwannoma: a double-blind, placebo-controlled, crossover study. Otol. Neurotol. 26 (2005) 169-176
8. Balaban C.D., Zhou J., and Li H.S. Type 1 vanilloid receptor expression by mammalian inner ear ganglion cells. Hear. Res. 175 (2003) 165-170
9. Balser J.R., Nuss H.B., Romashko D.N., Marban E., and Tomaselli G.F. Functional consequences of lidocaine binding to slow-inactivated sodium channels. J. Gen. Physiol. 107 (1996) 643-658
10. Bárány R. Die Beeinflussung des Ohrensausens durch intravenös injezierte Lokalanästhetika. Acta Otolaryngol. 23 (1935) 201-203
11. Bauer C.A. Mechanisms of tinnitus generation. Curr. Opin. Otolaryngol. Head Neck Surg. 12 (2004) 413-417
12. Bauer C.A., and Brozoski T.J. Effect of gabapentin on the sensation and impact of tinnitus. Laryngoscope 116 (2006) 675-681
13. Bauer C.A., Brozoski T.J., Holder T.M., and Caspary D.M. Effects of chronic salicylate on GABAergic activity in rat inferior colliculus. Hear. Res. 147 (2000) 175-182
14. Benson B.E., Carson R.E., Kiesewetter D.O., Herscovitch P., Eckelman W.C., Post R.M., and Ketter T.A. A potential cholinergic mechanism of procaine's limbic activation. Neuropsychopharmacology 29 (2004) 1239-1250
15. Bernhard C.G., Bohm E., and Hojeberg S. A new treatment of status epilepticus; intravenous injections of a local anesthetic (lidocaine). A.M.A. Arch. Neurol. Psychiatry 74 (1955) 208-214
16. Biella G., and Sotgiu M.L. Central effects of systemic lidocaine mediated by glycine spinal receptors: an iontophoretic study in the rat spinal cord. Brain Res. 603 (1993) 201-206
17. Boyes R.N., Scott D.B., Jebson P.J., Godman M.J., and Julian D.G. Pharmacokinetics of lidocaine in man. Clin. Pharmacol. Ther. 12 (1971) 105-116
18. v1.1. J. Physiol. 548 (2003) 1-20
19. Burm A.G., de Boer A.G., van Kleef J.W., Vermeulen N.P., de Leede L.G., Spierdijk J., and Breimer D.D. Pharmacokinetics of lidocaine and bupivacaine and stable isotope labelled analogues: a study in healthy volunteers. Biopharm. Drug Dispos. 9 (1988) 85-95
20. Butterworth IV J.F., and Strichartz G.R. Molecular mechanisms of local anesthesia: a review. Anesthesiology 72 (1990) 711-734
21. Cacace A.T. Expanding the biological basis of tinnitus: crossmodal origins and the role of neuroplasticity. Hear. Res. 175 (2003) 112-132
22. Cahana A., Carota A., Montadon M.L., and Annoni J.M. The long-term effect of repeated intravenous lidocaine on central pain and possible correlation in positron emission tomography measurements. Anesth. Analg. 98 (2004) 1581-1584
23. Cannon S.C., Brown Jr. R.H., and Corey D.P. Theoretical reconstruction of myotonia and paralysis caused by incomplete inactivation of sodium channels. Biophys. J. 65 (1993) 270-288
24. Caspary D.M., Schatteman T.A., and Hughes L.F. Age-related changes in the inhibitory response properties of dorsal cochlear nucleus output neurons: role of inhibitory inputs. J. Neurosci. 25 (2005) 10952-10959
25. Catterall W.A., Goldin A.L., and Waxman S.G. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol. Rev. 57 (2005) 397-409
26. Catterall W.A., Perez-Reyes E., Snutch T.P., and Striessnig J. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol. Rev. 57 (2005) 411-425
27. Chan V.W., Weisbrod M.J., Kaszas Z., and Dragomir C. Comparison of ropivacaine and lidocaine for intravenous regional anesthesia in volunteers: a preliminary study on anesthetic efficacy and blood level. Anesthesiology 90 (1999) 1602-1608
28. Connors B.W., and Prince D.A. Effects of local anesthetic QX-314 on the membrane properties of hippocampal pyramidal neurons. J. Pharmacol. Exp. Ther. 220 (1982) 476-481
29. Cooke E.D., Bowcock S.A., Lloyd M.J., and Pilcher M.F. Intravenous lignocaine in prevention of deep venous thrombosis after elective hip surgery. Lancet 2 (1977) 797-799
30. Courtney K.R. Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA. J. Pharmacol. Exp. Ther. 195 (1975) 225-236
31. 3H]batrachotoxin-A 20-α-benzoate binding in a vesicular preparation from guinea pig cerebral cortex. Mol. Pharmacol. 23 (1983) 350-358
32. Davies W.E. Future prospects for the pharmacologic treatment of tinnitus. Semin. Hear. 22 (2001) 89-100
33. Dietrich V., Nieschalk M., Stoll W., Rajan R., and Pantev C. Cortical reorganization in patients with high frequency cochlear hearing loss. Hear. Res. 158 (2001) 95-101
34. Dobie R.A. A review of randomized clinical trials in tinnitus. Laryngoscope 109 (1999) 1202-1211
35. Dodson K.M., and Sismanis A. Intratympanic perfusion for the treatment of tinnitus. Otolarnygol. Clin. N. Am. 37 (2004) 991-1000
36. Eggermont J.J. Tinnitus: neurobiological substrates. Drug Discov. Today 10 (2005) 1283-1290
37. + channels. Toxicol. Lett. 100-101 (1998) 277-285
38. Engel J., Braig C., Ruttiger L., Kuhn S., Zimmermann U., Blin N., Sausbier M., Kalbacher H., Munkner S., Rohbock K., Ruth P., Winter H., and Knipper M. Two classes of outer hair cells along the tonotopic axis of the cochlea. Neuroscience 143 (2006) 837-849
39. 14C-lidocaine in the inner ear. Preliminary clinical experience utilizing intravenous lidocaine in the treatment of severe tinnitus. Acta Otolaryngol. 82 (1976) 297-300
40. Evans E.F., Wilson J.P., and Borewe T.A. Animal model of tinnitus. CIBA Found. Synp. 85 (1981) 108-138
41. Fairhurst A.S., Whittaker M.L., and Ehlert F.J. Interactions of D600 (methoxyverapamil) and local anesthetics with rat brain alpha-adrenergic and muscarinic receptors. Biochem. Pharmacol. 29 (1980) 155-162
42. Finnerup N.B., Biering-Sørensen F., Johannesen I.L., Terkelsen A.J., Juhl G.I., Kristensen A.D., Sindrup S.H., Bach F.W., and Jensen T.S. Intravenous lidocaine relieves spinal cord injury pain: a randomized controlled study. Anesthesiology 102 (2005) 1023-1030
43. Fozzard H.A., Lee P.J., and Lipkind G.M. Mechanism of local anesthetic drug action on voltage-gated sodium channels. Curr. Pharm. Des. 11 (2005) 2671-2686
44. Fradis M., Podoshin L., Ben-David J., and Reiner B. Treatment of Meniere's disease by intratympanic injection with lidocaine. Arch. Otolaryngol. 111 (1985) 491-493
45. Franks N.P., and Lieb W.R. Which molecular targets are most relevant to general anaesthesia?. Toxicol. Lett. 100-101 (1998) 1-8
46. 2+ concentrations and causes dynamic contractions of the hearing organ. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 7127-7132
47. 2+-ATPase from rat brain synaptosomal membranes. J. Neurochem. 50 (1988) 248-256
48. Garcia-Martin E., Gonzalez-Cabanillas S., and Gutierrez-Merino C. Modulation of calcium fluxes across synaptosomal plasma membrane by local anesthetics. J. Neurochem. 55 (1990) 370-378
49. Gejrot T. Intravenous xylocaine in the treatment of attacks on Meniere's disease. Acta Otolaryngol. 82 (1976) 301-302
50. Grant G.J., Barenholz Y., Bolotin E.M., Bansinath M., Turndorf H., Piskoun B., and Davidson E.M. A novel liposomal bupivacaine formulation to produce ultralong-acting analgesia. Anesthesiology 101 (2004) 133-137
51. Grigg J.J., Brew H.M., and Tempel B.L. Differential expression of voltage-gated potassium channel genes in auditory nuclei of the mouse brainstem. Hear. Res. 140 (2000) 77-90
52. Guitton M.J., Caston J., Ruel J., Johnson R.M., Pujol R., and Puel J.L. Salicylate induces tinnitus through activation of cochlear NMDA receptors. J. Neurosci. 23 (2003) 3944-3952
53. Gutman G.A., Chandy G., Grissmer S., Lazdunski M., McKinnon D., Pardo L.A., Robertson G.A., Rudy B., Sanguinetti M.C., Stuhmer W., and Wang X. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol. Rev. 57 (2005) 473-508
54. Haeseler G., Bufler J., Merken S., Dengler R., Aronson J., and Leuwer M. Block of voltage-operated sodium channels by 2,6-dimethylphenol, a structural analogue of lidocaine's aromatic tail. Br. J. Pharmacol. 137 (2002) 285-293
55. Haginomori S., Makimoto K., Araki M., Kawakami M., and Takahashi H. Effect of lidocaine injection of EOAE in patients with tinnitus. Acta Otolaryngol. 115 (1995) 488-492
56. Hahnenkamp K., Durieux M.E., Hahnenkamp A., Schauerte S.K., Hoenemann C.W., Vegh V., Theilmeier G., and Hollmann M.W. Local anaesthetics inhibit signalling of human NMDA receptors recombinantly expressed in Xenopus laevis oocytes: role of protein kinase C. Br. J. Anaesth. 96 (2006) 77-87
57. v1.3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury. J. Neurosci. 23 (2003) 8881-8892
58. Hara M., Kai Y., and Ikemoto Y. Local anesthetics reduce the inhibitory neurotransmitter-induced current in dissociated hippocampal neurons of the rat. Eur. J. Pharmacol. 283 (1995) 83-89
59. den Hartigh J., Hilders C.G., Schoemaker R.C., Hulshof J.H., Cohen A.F., and Vermeij P. Tinnitus suppression by intravenous lidocaine in relation to its plasma concentration. Clin. Pharmacol. Ther. 54 (1993) 415-420
60. v3.1 tonotopicity and alterations in cAMP response element-binding protein signaling in central auditory neurons of hearing impaired mice. J. Neurosci. 24 (2004) 1936-1940
61. Hill A.V. The possible effects of the aggregation of the molecules of haemoglobin on its oxygen dissociation curve. J. Physiol. 40 (1910) 4-7
62. Hille B. Ionic channels of excitable membranes. 3rd ed. (2001), Sinauer Associates, Inc., Sunderland, MA
63. 2+ channels in rat cerebrocortical membranes. Br. J. Anaesth. 77 (1996) 248-253
64. Hirota K., Smart D., and Lambert D.G. The effects of local and intravenous anesthetics on recombinant rat VR1 vanilloid receptors. Anesth. Analg. 96 (2003) 1656-1660
65. Hofer D., Lohberger B., Steinecker B., Schmidt K., Quasthoff S., and Schreibmayer W. A comparative study of the action of tolperisone on seven different voltage dependent sodium channel isoforms. Eur. J. Pharmacol. 538 (2006) 5-14
66. Hollmann M.W., and Durieux M.E. Local anesthetics and the inflammatory response: a new therapeutic indication?. Anesthesiology 93 (2000) 858-875
67. Hollmann M.W., Durieux M.E., and Graf B.M. Novel local anaesthetics and novel indications for local anaesthetics. Curr. Opin. Anaesthesiol. 14 (2001) 741-749
68. Hollmann M.W., Fischer L.G., Byford A.M., and Durieux M.E. Local anesthetic inhibition of m1 muscarinic acetylcholine signaling. Anesthesiology 93 (2000) 497-509
69. Hollmann M.W., Herroeder S., Kurz K.S., Hoenemann C.W., Struemper D., Hahnenkamp K., and Durieux M.E. Time-dependent inhibition of G protein-coupled receptor signaling by local anesthetics. Anesthesiology 100 (2004) 852-860
70. Hossain W.A., Antic S.D., Yang Y., Rasband M.N., and Morest D.K. Where is the spike generator of the cochlear nerve? Voltage-gated sodium channels in the mouse cochlea. J. Neurosci. 25 (2005) 6857-6868
71. Hotz M.A., Harris F.P., and Probst R. Otoacoustic emissions: an approach for monitoring aminoglycoside-induced ototoxicity. Laryngoscope 104 (1994) 1130-1134
72. Housley G.D., and Ashmore J.F. Ionic currents of outer hair cells isolated from the guinea-pig cochlea. J. Physiol. 448 (1992) 73-98
73. Hughes D.W., and Yagi T. Lidocaine hydrochloride depression of cochlear microphonics and action potentials in cat. Auris Nasus Larynx 2 (1975) 107-116
74. Isom L.L. Sodium channel beta subunits: anything but auxiliary. Neuroscientist 7 (2001) 42-54
75. Itoh A., and Sakata E. Treatment of vestibular disorders. Acta Otolaryngol. Suppl. 481 (1991) 617-623
76. Jastreboff P.J., Brennan J.F., and Sasaki C.T. Quinine-induced tinnitus in rats. Arch. Otolaryngol. Head Neck Surg. 117 (1991) 1162-1166
77. Javel E., Mouney D.F., McGee J., and Walsh E.J. Auditory brainstem responses during systemic infusion of lidocaine. Arch. Otolaryngol. Head Neck Surg. 108 (1982) 71-76
78. Johnson R.M., Brummett R., and Schleuning A. Use of alprazolam for relief of tinnitus: a double-blind study. Arch. Otolaryngol. Head Neck Surg. 119 (1993) 842-845
79. Kalcioglu M.T., Bayindir T., Erdem T., and Ozturan O. Objective evaluation of the effects of intravenous lidocaine on tinnitus. Hear. Res. 199 (2005) 81-88
80. Kaltenbach J.A., and Zhang J. Intense sound-induced plasticity in the dorsal cochlear nucleus of rats: evidence for cholinergic receptor upregulation. Hear. Res. 226 (2007) 232-243
81. Kaltenbach J.A., Zhang J., and Finlayson P. Tinnitus as a plastic phenomenon and its possible neural underpinnings in the dorsal cochlear nucleus. Hear. Res. 206 (2005) 200-226
82. Kemp D.T. Stimulated acoustic emissions from within the human auditory system. J. Acoust. Soc. Am. 64 (1978) 1386-1391
83. Kennedy H.J., Crawford A.C., and Fettiplace R. Force generation by mammalian hair bundles supports a role in cochlear amplification. Nature 433 (2005) 880-883
84. + channels implicate sensory outer hair cells in human progressive deafness. EMBOJ 25 (2006) 642-652
85. + channels lacking inactivation: features of a transition-intermediate mechanism. J. Physiol. 529 (2000) 93-106
86. Konishi T., and Kelsey E. Effect of tetrodotoxin and procaine on cochlear potentials. J. Acoust. Soc. Am. 43 (1968) 471-480
87. B receptors and synaptic modulation. Cell Tissue Res. 326 (2006) 517-533
88. Kwon Y.W., and Triggle D. Interactions of local anesthetics with neuronal 1,4-dihydropyridine binding sites. Biochem. Pharmacol. 42 (1991) 213-216
89. Laurikainen E.A., Johansson R.K., and Kileny P.R. Effects of intratympanically delivered lidocaine on the auditory system in humans. Ear Hear. 17 (1996) 49-54
90. Laurikainen E., Marttila R., Lindberg R., and Kanto J. Penetration of lidocaine and its active desethylated metabolite into cerebrospinal fluid in man. Eur. J. Clin. Pharmacol. 25 (1983) 639-641
91. Laurikainen E., Nuttall A.L., Miller J.M., Quirk W.S., and Virolainen E. Experimental basis for lidocaine therapy in cochlear disorders. Acta Otolaryngol. 112 (1992) 800-809
92. Laurikainen E., Lin X., Nuttall A.L., and Dolan D.F. The mechanism and site of action of lidocaine hydrochloride in guinea pig inner ear. Acta Otolaryngol. 117 (1997) 523-528
93. + conductances and enhanced central excitability in a congenitally deaf (dn/dn) mouse. J. Physiol. 559 (2004) 25-33
94. Lechtenberg R., and Shulman A. Benzodiazepines in the treatment of tinnitus. J. Laryngol. Otol. 9 (1984) 271-276
95. Lenarz T. Treatment of tinnitus with lidocaine and tocainide. Scand. Audiol. 26 (1986) 49-51
96. Li J., Olinger A.B., Dassow M.S., and Abel M.S. Up-regulation of GABA(B) receptor mRNA and protein in the hippocampus of cocaine- and lidocaine-kindled rats. Neuroscience 118 (2003) 451-462
97. Li W., Kaczmarek L.K., and Perney T.M. Localization of two high-threshold potassium channel subunits in the rat central auditory system. J. Comp. Neurol. 437 (2001) 196-218
98. Liberman M.C., and Kiang N.Y. Acoustic trauma in cats. Cochlear pathology and auditory-nerve activity. Acta Otolaryngol. Suppl. 358 (1978) 1-63
99. Ling L.L., Hughes L.F., and Caspary D.M. Age-related loss of the GABA synthetic enzyme glutamic acid decarboxylase in rat primary auditory cortex. Neuroscience 132 (2005) 1103-1113
100. A receptors. Br. J. Anaesth. 90 (2003) 199-211
101. v3.1 potassium channel and reduce the ability of inferior colliculus neurons to fire at high frequencies. J. Neurobiol. 62 (2005) 439-452
102. Lockwood A.H., Salvi R.J., Coad M.L., Towsley M.L., Wack D.S., and Murphy B.W. The functional neuroanatomy of tinnitus: evidence for limbic system links and neural plasticity. Neurology 50 (1998) 114-120
103. v3.1. J. Comp. Neurol. 470 (2004) 93-106
104. Lyttkens L., Larsson B., Göller H., Englesson S., and Stahle J. Melanine capacity to accumulate drugs in the internal ear. A study on lidocaine, bupivacaine and chlorpromazine. Acta Otolaryngol. 88 (1979) 61-73
105. Lyttkens L., Larsson B., and Wasterstrom S.A. Local anaesthetics and tinnitus. Proposed peripheral mechanism of action of lidocaine. ORL J. Otorhinolaryngol. Relat. Spec. 46 (1984) 17-23
106. Manabe Y., Yoshida S., Saito H., and Oka H. Effects of lidocaine on salicylate-induced discharge of neurons in the inferior colliculus of the guinea pig. Hear. Res. 103 (1997) 192-198
107. Martin W.H., Schwegler J.W., Scheibelhoffer J., and Ronis M.L. Salicylate-induced changes in cat auditory nerve activity. Laryngoscope 103 (1993) 600-604
108. Maruyama J., Kobayashi T., Sugimoto A., and Gyo K. Effects of lidocaine on basilar membrane vibration in the guinea pig. Acta Otolaryngol. 121 (2001) 803-807
109. Max M.B., and Hagen N.A. Do changes in brain sodium channels cause central pain?. Neurology 54 (2000) 544-545
110. McMahon C.M., and Patuzzi R.B. The origin of the 900 Hz spectral peak in spontaneous and sound-evoked round-window electrical activity. Hear. Res. 173 (2002) 134-152
111. Mezey E., Toth Z.E., Cortright D.N., Arzubi M.K., Krause J.E., Elde R., Guo A., Blumberg P.M., and Szallasi A. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 3655-3660
112. Mirz F., Pedersen B., Ishizu K., Johannsen P., Ovesen T., Stodkilde-Jorgensen H., and Gjedde A. Positron emission tomography of cortical centers of tinnitus. Hear. Res. 134 (1999) 133-144
113. Modica P.A., Tempelhoff R., and White P.F. Pro- and anticonvulsant effects of anesthetics (Part II). Anesth. Analg. 70 (1990) 433-444
114. Møller A.R. Similarities between severe tinnitus and chronic pain. J. Am. Acad. Audiol. 11 (2000) 115-124
115. Møller A.R. Hearing: Anatomy, Physiology, and Disorders of the Auditory System. 2nd ed. (2006), Academic Press, Amsterdam
116. Møller A.R. Neural plasticity and disorders of the nervous system (2006), Cambridge University Press, Cambridge
117. Møller A.R., and Jannetta P.J. Interpretation of brainstem auditory evoked potentials: results from intracranial recordings in humans. Scand. Audiol. (Stockh.) 12 (1983) 125-133
118. Møller A.R., Møller M.B., and Yokota M. Some forms of tinnitus may involve the extralemniscal auditory pathway. Laryngoscope 102 (1992) 1165-1171
119. Murai K., Tyler R.S., Harker L.A., and Stouffer J.L. Review of pharmacologic treatment of tinnitus. Am. J. Otol. 13 (1992) 454-464
120. Nagy I., and Woolf C.J. Lignocaine selectively reduces C fibre-evoked neuronal activity in rat spinal cord in vitro by decreasing N-methyl-d-aspartate and neurokinin receptor-mediated post-synaptic depolarizations; implications for the development of novel centrally acting analgesics. Pain 64 (1996) 59-70
121. Nakazono T., Murakami T., Higashi Y., and Yata N. Study on brain uptake of local anesthetics in rats. J. Pharmacobiodyn. 14 (1991) 605-613
122. Nishizawa N., Shirasaki T., Nakao S., Matsuda H., and Shingu K. The inhibition of the N-methyl-d-aspartate receptor channel by local anesthetics in mouse CA1 pyramidal neurons. Anesth. Analg. 94 (2002) 325-330
123. Nitsche M.A., Liebetanz D., Paulus W., and Tergau F. Pharmacological characterisation and modulation of neuroplasticity in humans. Curr. Neuropharmacol. 3 (2005) 217-229
124. B responses using patch-clamp recordings in rat hippocampal slices. J. Physiol. 463 (1993) 391-407
125. Parnes S.M., Spektor Z., and Strominger N. Effects of lidocaine infusion in cats after unilateral labyrinthectomy. Arch. Otolaryngol. Head Neck Surg. 114 (1988) 653-656
126. Perkins K.L., and Wong R.K. Intracellular QX-314 blocks the hyperpolarization-activated inward current Iq in hippocampal CA1 pyramidal cells. J. Neurophysiol. 73 (1995) 911-915
127. Perucca E., and Jackson P. A controlled study of the suppression of tinnitus by lidocaine infusion: relationship of therapeutic effect with serum lidocaine levels. J. Laryngol. Otol. 99 (1985) 657-661
128. v1.1, causes megencephaly. Eur. J. Neurosci. 18 (2003) 3231-3240
129. Petralia R.S., Rubio M.E., Wang Y.X., and Wenthold R.J. Differential distribution of glutamate receptors in the cochlear nuclei. Hear. Res. 147 (2000) 59-69
130. 3H]batrachotoxinin A 20-α-benzoate to sodium channels by local anesthetics. Mol. Pharmacol. 25 (1984) 219-227
131. Pyykko I., Padoan S., Schalen L., Lyttkens L., Magnusson M., and Henriksson N.G. The effects of TTS-scopolamine, dimenhydrinate, lidocaine, and tocainide on motion sickness, vertigo, and nystagmus. Aviat. Space Environ. Med. 56 (1985) 777-782
132. 2+ in cochlear outer hair cells. J. Physiol. 579 (2007) 101-113
133. Reed H.T., Meltzer J., Crews P., Norris C.H., Quine D.B., and Guth P.S. Amino-oxyacetic acid as a palliative in tinnitus. Arch. Otolaryngol. Head Neck Surg. 111 (1985) 803-805
134. Reyes S.A., Salvi R.J., Burkard R.F., Coad M.L., Wack D.S., Galantowicz P.J., and Lockwood A.H. Brain imaging the effects of lidocaine on tinnitus. Hear. Res. 171 (2002) 43-50
135. Rolf S., Haverkamp W., Borggrefe M., Musshoff U., Eckardt L., Mergenthaler J., Snyders D.J., Pongs O., Speckmann E.J., Breithardt G., and Madeja M. Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes. Naunyn Schmiedebergs Arch. Pharmacol. 362 (2000) 22-31
136. Routledge P.A., Barchowsky A., Bjornsson T.D., Kitchell B.B., and Shand D.G. Lidocaine plasma protein binding. Clin. Pharmacol. Ther. 27 (1980) 347-351
137. Ruth R.A., Gal T.J., DiFazio C.A., and Moscicki J.C. Brainstem auditory-evoked potentials during lidocaine infusion in humans. Arch. Otolaryngol. 111 (1985) 799-802
138. Rydén L. Evaluation of a new antiarrhythmic drug. Acta Med. Scand. 569 (1974) 1-40
139. Sakamoto K., Karikomi Y., Kubota Y., Nakahara T., and Ishii K. Characterization of mexiletine as an antagonist of beta-adrenoceptor in Chinese hamster ovary cells expressing cloned human beta-adrenoceptors. Biochem. Pharmacol. 67 (2004) 815-822
140. Salazar B.C., Flash D., Walewski J.L., and Recio-Pinto E. Lidocaine has different effects and potencies on muscle and brain sodium channels. Brain Res. 699 (1995) 305-314
141. Salvi R.J., Wang J., and Ding D. Auditory plasticity and hyperactivity following cochlear damage. Hear. Res. 147 (2000) 261-274
142. Santos-Sacchi J., and Dilger J.P. Whole cell currents and mechanical responses of isolated outer hair cells. Hear. Res. 35 (1988) 143-150
143. Savastano M. Lidocaine intradermal injection - a new approach in tinnitus therapy: preliminary report. Adv. Ther. 21 (2004) 13-20
144. Shen J., Harada N., Kubo N., Liu B., Mizuno A., Suzuki M., and Yamashita T. Functional expression of transient receptor potential vanilloid 4 in the mouse cochlea. Neuroreport 17 (2006) 135-139
145. Shiomi Y., Funabiki K., Naito Y., Fujiki N., and Tsuji J. The effect of intravenous lidocaine injection on hearing thresholds. Auris Nasus Larynx 24 (1997) 351-356
146. Simpson J.J., and Davies W.E. Recent advances in the pharmacological treatment of tinnitus. Trends Pharmacol. Sci. 20 (1999) 12-18
147. Slepecky N., Ulfendahl M., and Flock A. Effects of caffeine and tetracaine on outer hair cell shortening suggest intracellular calcium involvement. Hear. Res. 32 (1988) 11-21
148. Smith J.A., Amagasu S.M., Hembrador J., Axt S., Chang R., Church T., Gee C., Jacobsen J.R., Jenkins T., Kaufman E., Mai N., and Vickery R.G. Evidence for a multivalent interaction of symmetrical, N-linked, lidocaine dimers with voltage-gated Na+ channels. Mol. Pharmacol. 69 (2006) 921-931
149. Smith P.F., and Darlington C.L. Drug treatments for subjective tinnitus: serendipitous discovery versus rational drug design. Curr. Opin. Investig. Drugs 6 (2005) 712-716
150. Staffen W., Biesinger E., Trinka E., and Ladurner G. The effect of lidocaine on chronic tinnitus: a quantitative cerebral perfusion study. Audiology 38 (1999) 53-57
151. Steen P.A., and Michenfelder J.D. Neurotoxicity of anesthetics. Anesthesiology 50 (1979) 437-453
152. Strebel S., Frei F., Rosow C.E., and Drewe J. Central nervous system symptoms after intravenous lignocaine: dose-response during pregnancy. Eur. J. Anaesthesiol. 10 (1993) 101-104
153. A receptors. Eur. J. Pharmacol. 401 (2000) 329-337
154. Sugimoto M., Uchida I., and Mashimo T. Local anaesthetics have different mechanisms and sites of action at the recombinant N-methyl-d-aspartate (NMDA) receptors. Br. J. Pharmacol. 138 (2003) 876-882
155. Suneja S.K., Benson C.G., and Potashner S.J. Glycine receptors in adult guinea pig brain stem auditory nuclei: regulation after unilateral cochlear ablation. Exp. Neurol. 154 (1998) 473-488
156. Szczepaniak W.S., and Møller A.R. Evidence of neuronal plasticity within the inferior colliculus after noise exposure: a study of evoked potentials in the rat. Electroencephalogr. Clin. Neurophysiol. 100 (1996) 158-164
157. Tetzlaff J.E. Clinical Pharmacology of Local Anesthetics (1999), Butterworth-Heinemann, Boston, MA
158. Trellakis S., Benzenberg D., Urban B.W., and Friederich P. Differential lidocaine sensitivity of human voltage-gated potassium channels relevant to the auditory system. Otol. Neurotol. 27 (2006) 117-123
159. Tucker G.T., Boyes R.N., Bridenbaugh P.O., and Moore D.C. Binding of anilide-type local anesthetics in human plasma: I. Relationships between binding, physicochemical properties, and anesthetic activity. Anesthesiology 33 (1970) 287-303
160. Ueda H., Nakata S., and Hoshino M. Effects of effusion in the middle ear and perforation of the tympanic membrane on otoacoustic emissions in guinea pigs. Hear. Res. 122 (1998) 41-46
161. Ueda S., Aso S., Watanabe Y., and Mizukoshi K. Changes in auditory evoked responses during intravenous lidocaine. Acta Otolaryngol. 504 (1993) 89-93
162. Urban B.W. Current assessment of targets and theories of anaesthesia. Br. J. Anaesth. 89 (2002) 167-183
163. Van Den Abbeele T., Teulon J., and Huy P.T. Two types of voltage-dependent potassium channels in outer hair cells from the guinea pig cochlea. Am. J. Physiol. 277 (1999) 913-925
164. Velasco M., Velasco F., Pacheco M.T., Martinez A., and Olvera A. Subcortical correlates of the auditory brainstem potentials in the monkey: referential responses. Int. J. Neurosci. 17 (1982) 199-208
165. Wangemann P., Shiga N., Welch C., and Marcus D.C. Evidence for the involvement of a K+ channel in isosmotic cell shrinking in vestibular dark cells. Am. J. Physiol. 263 (1992) 616-622
166. v1.1 potassium channel gating by a combined surface potential and cooperative subunit interaction mechanism. J. Physiol. 550 (2003) 51-66
167. Weinmeister K.P. Prolonged suppression of tinnitus after peripheral nerve block using bupivacaine and lidocaine. Reg. Anesth. Pain Med. 25 (2000) 67-68
168. v1.2 channels. Neurosci. Lett. 395 (2006) 179-184
169. Witt C.M., Hu H.Y., Brownell W.E., and Bertrand D. Physiologically silent sodium channels in mammalian outer hair cells. J. Neurophysiol. 72 (1994) 1037-1040
170. 2+ channels in rat anterior pituitary cells. Eur. J. Pharmacol. 363 (1998) 81-90
171. Xu F., Garavito-Aguilar Z., Recio-Pinto E., Zhang J., and Blanck T.J. Local anesthetics modulate neuronal calcium signaling through multiple sites of action. Anesthesiology 98 (2003) 1139-1146
172. Yi B.A., Minor Jr. D.L., Lin Y.F., Jan Y.N., and Jan L.Y. Controlling potassium channels activities: interplay between the membrane and intracellular factors. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 11016-11023
173. Zheng J., Dai C., Steyger P.S., Kim Y., Vass Z., Ren T., and Nuttall A.L. Vanilloid receptors in hearing: altered cochlear sensitivity by vanilloids and expression of TRPV1 in the organ of Corti. J. Neurophysiol. 90 (2003) 444-455